Date published: 2026-5-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

GSC Inhibitors

GSC inhibitors are a class of chemical compounds that target Goosecoid (GSC), a homeobox transcription factor involved in the regulation of embryonic development, particularly in the formation of body axes and organogenesis. GSC plays a key role in controlling the expression of genes that are critical for mesodermal and neural development. It acts as a transcriptional repressor, regulating various signaling pathways that guide cell fate determination, tissue differentiation, and morphogenetic movements during early development. Inhibitors of GSC disrupt its ability to bind to DNA and regulate gene expression, thus affecting the cellular processes and developmental pathways that rely on precise control of gene activation and repression.

The mechanism of action of GSC inhibitors generally involves binding to the DNA-binding domain of the GSC protein, preventing it from interacting with its target gene sequences or with other regulatory proteins essential for transcriptional repression. By inhibiting GSC function, these compounds can alter the transcriptional landscape within cells, disrupting normal patterns of gene expression that are crucial for development. Researchers utilize GSC inhibitors to study the molecular mechanisms by which GSC regulates embryonic patterning and how disruptions in its function affect cellular differentiation and tissue formation. These inhibitors provide valuable insights into the role of transcription factors in orchestrating complex developmental processes and offer a deeper understanding of the regulatory networks that control early embryogenesis and the establishment of body plans.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Temozolomide

85622-93-1sc-203292
sc-203292A
25 mg
100 mg
$91.00
$255.00
32
(1)

Alkylating agent that interferes with DNA replication, leading to cell cycle arrest and apoptosis, potentially inhibiting GSC proliferation.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Src kinase inhibitor that disrupts multiple signaling pathways involved in cell proliferation and survival, potentially inhibiting GSC growth.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor that disrupts protein degradation pathways, leading to cell cycle arrest and apoptosis, potentially inhibiting GSC growth.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor that targets RAF/MEK/ERK signaling, angiogenesis, and receptor tyrosine kinases, potentially inhibiting GSC proliferation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that disrupts cell signaling pathways involved in cell growth and proliferation, potentially inhibiting GSC proliferation.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Pan-histone deacetylase inhibitor that alters gene expression and induces apoptosis, potentially inhibiting GSC survival and proliferation.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR tyrosine kinase inhibitor that disrupts downstream signaling pathways, potentially suppressing GSC proliferation and survival.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

BCR-ABL tyrosine kinase inhibitor that blocks multiple signaling pathways, potentially inhibiting GSC growth and survival.

Leflunomide

75706-12-6sc-202209
sc-202209A
10 mg
50 mg
$20.00
$83.00
5
(1)

DHODH inhibitor that disrupts pyrimidine synthesis, potentially affecting DNA replication and inhibiting GSC proliferation.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Platinum-based chemotherapeutic agent that forms DNA adducts, inducing DNA damage and apoptosis, potentially inhibiting GSC growth.